SCHEMBL22949335

SCHEMBL22949335

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc5c(c4)[Si](c4cccc6ccccc46)(c4cccc6ccccc46)c4ccccc4-5)cc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.40
ALDH1A1 P00352 5/20 0.40
HPGD P15428 5/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
ATM Q13315 3/20 0.40
KDM4E B2RXH2 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
TSHR P16473 2/20 0.40
MAPK1 P28482 2/20 0.40
HSD17B10 Q99714 2/20 0.40
TP53 P04637 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CA12 O43570 4/20 0.37
CA1 P00915 4/20 0.37
CA2 P00918 4/20 0.37
CA9 Q16790 4/20 0.37
MEN1 O00255 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947659 1.00 MAPT (0.40) MAPTALDH1A1HPGDSMN1; SMN2ATM
SCHEMBL22947558 0.97 ALDH1A1 (0.40) MAPTALDH1A1HPGDSMN1; SMN2ATM
SCHEMBL22949670 0.96 MAPT (0.41) MAPTALDH1A1HPGDSMN1; SMN2ATM
SCHEMBL22949691 0.95 MAPT (0.39) MAPTALDH1A1HPGDSMN1; SMN2ATM
SCHEMBL22947667 0.95 MAPT (0.39) MAPTALDH1A1HPGDSMN1; SMN2ATM
SCHEMBL22947656 0.94 MAPT (0.38) MAPTALDH1A1HPGDSMN1; SMN2ATM
SCHEMBL22949381 0.92 MAPT (0.39) MAPTALDH1A1HPGDSMN1; SMN2ATM
SCHEMBL22949123 0.92 ALDH1A1 (0.39) MAPTALDH1A1HPGDSMN1; SMN2ATM
SCHEMBL22947598 0.91 MAPT (0.40) MAPTALDH1A1HPGDSMN1; SMN2ATM
SCHEMBL22947665 0.89 MAPT (0.36) MAPTALDH1A1HPGDSMN1; SMN2ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 MAPT 3103/4885ALDH1A1 752/4885HPGD 2601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.